San Jose, CA, United States of America

Gang Herbert Lin

This inventor holds 28 USPTO granted patents and 2 published patent applications and 3 EPO patents, primarily in Proteasome Inhibitors. Top assignees: Cornell University, Maxtor Corporation, Western Digital Technologies, Inc.. Active years: 1997-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gang Herbert Lin. Retrieved from https://idiyas.com/inventor/gang-herbert-lin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 28 

% Patents Active = 67.9

 

Average Co-Inventor Count = 3.3

ph-index = 12

Forward Citations = 424(Granted Patents)


Location History:

  • Ruston, LA (US) (1997)
  • New York, NY (US) (2011)
  • San Jose, CA (US) (2000 - 2013)
  • Forest Hills, NY (US) (2018 - 2024)

Company Filing History:


Years Active: 1997-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Proteasome Inhibitors
Macrocyclic Compounds
Dipeptidomimetics
Human Immunoproteasomes
Peptidomimetic
Inflammatory Disorders
Disk Drive Components
Magnetic Storage Devices
Thermal Expansion
Neutrophil Activation
Data Storage System
Chemical Inhibitors
28 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Gang Herbert Lin - Pioneering Proteasome Inhibitors

Introduction:

Gang Herbert Lin, a prolific inventor based in San Jose, CA, has made significant contributions to the field of pharmaceuticals with a focus on developing macrocyclic and peptidomimetic compounds as proteasome inhibitors. His innovative approach has led to 25 patents and groundbreaking advancements in the treatment of various diseases.

Latest Patents:

Lin's groundbreaking patents include the development of macrocyclic compounds as proteasome inhibitors. These compounds play a crucial role in treating a wide range of conditions including bacterial infections, parasite infections, cancer, autoimmune disorders, and neurodegenerative diseases. Additionally, his work on peptidomimetic proteasome inhibitors further expands the potential applications in areas such as immunology and transplantation medicine.

Career Highlights:

Lin's career has been marked by collaborations with leading institutions and companies. He has made significant contributions during his tenure at Maxtor Corporation and Cornell University, where he honed his skills as a pioneering inventor in the pharmaceutical industry. Lin's dedication to research and development has cemented his reputation as a trailblazer in the field of proteasome inhibitors.

Collaborations:

Throughout his career, Gang Herbert Lin has collaborated with esteemed professionals such as Carl F. Nathan and Tao Lin. These collaborations have been instrumental in advancing the field of proteasome inhibitors and exploring new avenues for the application of macrocyclic and peptidomimetic compounds in healthcare.

Conclusion:

In conclusion, Gang Herbert Lin's innovative spirit and dedication to scientific exploration have positioned him as a leading figure in the development of proteasome inhibitors. His impactful patents and successful collaborations underscore his commitment to advancing medical treatments and improving patient outcomes. Gang Herbert Lin continues to inspire future generations of inventors with his groundbreaking work in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…